Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), today announced that it has commenced an underwritten public offering of its common stock pursuant to a shelf registration statement that was previously filed with and declared effective by the Securities and Exchange Commission (SEC). All of the shares in the offering are to be sold by the Company. In addition, the Company is expected to grant the underwriter of the offering a 30-day option to purchase up to an addition